Adicet Bio (FRA:1IJ) OCF Yield %: -108.56 (As of Jul. 06, 2026)


FRA:1IJ Adicet Bio Inc FRA:1IJ
31 GF Score
Price €7.55
! 3 Warning Signs
View Full Analysis

What is Adicet Bio OCF Yield %?

Adicet Bio FRA:1IJ +4.14% 31 OCF Yield % is -108.56 as of Jul. 06, 2026. GuruFocus rates FRA:1IJ with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 1,410 Biotechnology companies, Adicet Bio ranks worse than 91.99% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Adicet Bio's Trailing 12-Month Cash Flow from Operations is €-78.54 Mil, and Market Cap is €73.88 Mil. Therefore, Adicet Bio's OCF Yield % for today is -108.56%.

The historical rank and industry rank for Adicet Bio's OCF Yield % or its related term are showing as below:

FRA:1IJ' s OCF Yield % Range Over the Past 10 Years
Min: -259.42   Med: -46.96   Max: -3.33
Current: -108.56


During the past 8 years, the highest OCF Yield % of Adicet Bio was -3.33%. The lowest was -259.42%. And the median was -46.96%.

FRA:1IJ's OCF Yield % is ranked worse than
91.99% of 1410 companies
in the Biotechnology industry
Industry Median: -7.975 vs FRA:1IJ: -108.56

Adicet Bio's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Adicet Bio OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Adicet Bio OCF Yield % Related Terms


Adicet Bio OCF Yield % Historical Data

* Premium members only.

The historical data trend for Adicet Bio's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adicet Bio OCF Yield % Chart

Adicet Bio Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -8.18 -12.45 -131.72 -129.26 -135.34

Adicet Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -162.43 -208.55 -138.89 -118.84 -153.41

FRA:1IJ vs EDSA, GOSS, HRTX: OCF Yield % Comparison

For the Biotechnology subindustry, Adicet Bio's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adicet Bio OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adicet Bio's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Adicet Bio's OCF Yield % falls into.


FRA:1IJ
31GF Score
Adicet Bio Inc FRA:1IJ
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adicet Bio OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Adicet Bio's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-81.34 / 60.0989856
=-135.34%

Adicet Bio's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-18.589 * 4 / 48.4699
=-153.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -108.56 mean?
Adicet Bio (FRA:1IJ) has a OCF Yield % of -108.56 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Adicet Bio and its competitors. According to the industry distribution chart, Adicet Bio ranks #1297 out of 1410 companies in the Biotechnology industry, placing it in the top 92%.
Is Adicet Bio's OCF Yield % too high?
Adicet Bio's current OCF Yield % is -108.56. Based on the distribution chart, Adicet Bio ranks #1297 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Adicet Bio has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Adicet Bio's OCF Yield % compare to EDSA and GOSS?
According to the Biotechnology industry distribution chart, Adicet Bio ranks #1297 out of 1410 companies for OCF Yield %. This places Adicet Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Adicet Bio and its competitors. Adicet Bio's current OCF Yield % is -108.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicet Bio stock overvalued right now?
Adicet Bio (FRA:1IJ) has a current OCF Yield % of -108.56. The current OCF Yield % is -108.56. Adicet Bio's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Adicet Bio (FRA:1IJ), the current OCF Yield % is -108.56 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adicet Bio Business Description

Other Exchanges ACET:USA0HX7:UK
Address 131 Dartmouth Street, 3rd Floor, Boston, MA, USA, 02116
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
31GF Score

Get the complete analysis for FRA:1IJ

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.55
Price